Marketing-authorisation holder · Canada
Merck Canada Inc
179 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Canada
179 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 179
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| BRIDION100 mg / ml · Solution | Sugammadex | Canada | Marketed | 2016 |
| CANCIDAS70 mg / vial · Powder For Solution | Caspofungin | Canada | Marketed | 2001 |
| CAPVAXIVE65 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml + 4 mcg / 0.5 ml · Solution | Corynebacterium diphtheriae crm-197 protein, Pneumococcal polysaccharide serotype, Pneumococcal polysaccharide serotype deoac | Canada | Marketed | 2024 |
| DELSTRIGO100 mg + 300 mg + 300 mg · Tablet | Doravirine, Lamivudine, Tenofovir disoproxil | Canada | Marketed | 2018 |
| DIFICID200 mg · Tablet | Fidaxomicin | Canada | Marketed | 2012 |
| EMEND80 mg · Capsule | Aprepitant | Canada | Marketed | 2007 |
| EMEND125 mg · Capsule | Aprepitant | Canada | Marketed | 2007 |
| EMEND IV150 mg / vial · Powder For Solution | Aprepitant | Canada | Marketed | 2011 |
| EMEND TRI-PACK125 mg + 80 mg · Capsule, Kit | Aprepitant | Canada | Marketed | 2007 |
| ENFLONSIA105 mg / 0.7 ml · Solution | Clesrovimab | Canada | Authorised | |
| ERVEBO72000000 pfu / ml · Solution | Ebola vaccines | Canada | Authorised | |
| GARDASIL 940 mcg / 0.5 ml + 60 mcg / 0.5 ml + 40 mcg / 0.5 ml + 20 mcg / 0.5 ml + 20 mcg / 0.5 ml + 20 mcg / 0.5 ml + 20 mcg / 0.5 ml + 20 mcg / 0.5 ml + 30 mcg / 0.5 ml · Suspension | Recombinant human papillomavirus type l1 protein | Canada | Marketed | 2015 |
| IDVYNSO100 mg + 0.25 mg · Tablet | Doravirine, Islatravir | Canada | Authorised | |
| INVANZ1 g / vial · Powder For Solution | Ertapenem | Canada | Marketed | 2003 |
| ISENTRESS400 mg · Tablet | Raltegravir | Canada | Marketed | 2007 |
| ISENTRESS HD600 mg · Tablet | Raltegravir | Canada | Marketed | 2017 |
| JANUMET1000 mg + 50 mg · Tablet | Metformin, Sitagliptin | Canada | Marketed | 2009 |
| JANUMET500 mg + 50 mg · Tablet | Metformin, Sitagliptin | Canada | Marketed | 2009 |
| JANUMET XR1000 mg + 100 mg · Tablet (Extended-Release) | Metformin, Sitagliptin | Canada | Marketed | 2015 |
| JANUMET XR1000 mg + 50 mg · Tablet (Extended-Release) | Metformin, Sitagliptin | Canada | Marketed | 2014 |
| JANUMET XR500 mg + 50 mg · Tablet (Extended-Release) | Metformin, Sitagliptin | Canada | Marketed | 2015 |
| JANUVIA100 mg · Tablet | Sitagliptin | Canada | Marketed | 2008 |
| JANUVIA25 mg · Tablet | Sitagliptin | Canada | Marketed | 2012 |
| JANUVIA50 mg · Tablet | Sitagliptin | Canada | Marketed | 2012 |
| KEYTRUDA25 mg / ml · Solution | Pembrolizumab | Canada | Marketed | 2017 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 179 | 59 | 120 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.